-transparent.png){kind=logo}
The aim of this study was to investigate the efficacy, tolerability, and safety of isradipine in hypertensive diabetic patients. Twenty-eight patients (14 men and 14 women), of whom 15 had type II (non-insulin-dependent) and 13 had type I (insulin-dependent) diabetes mellitus, received isradipine for 6 months. A significant reduction was observed in both systolic and diastolic blood pressures (P < .00005). There were no significant differences between the type I and type II diabetes patients; metabolic control remained stable. Moderate or slight headaches were reported by four patients. In conclusion, the overall efficacy of isradipine and its tolerability were found to be very good.
J M Parreira, and
L G Correia, and
E Pereira, and
R S Duarte, and
E Pape
January 2005,
International braz j urol : official journal of the Brazilian Society of Urology,
J M Parreira, and
L G Correia, and
E Pereira, and
R S Duarte, and
E Pape
January 2003,
Kardiologiia,
J M Parreira, and
L G Correia, and
E Pereira, and
R S Duarte, and
E Pape
July 2006,
Current medical research and opinion,
J M Parreira, and
L G Correia, and
E Pereira, and
R S Duarte, and
E Pape
December 1994,
Angiology,
J M Parreira, and
L G Correia, and
E Pereira, and
R S Duarte, and
E Pape
February 1991,
American journal of hypertension,
J M Parreira, and
L G Correia, and
E Pereira, and
R S Duarte, and
E Pape
January 1994,
The American journal of medicine,
J M Parreira, and
L G Correia, and
E Pereira, and
R S Duarte, and
E Pape
February 1991,
American journal of hypertension,
J M Parreira, and
L G Correia, and
E Pereira, and
R S Duarte, and
E Pape
July 1994,
Journal of human hypertension,
J M Parreira, and
L G Correia, and
E Pereira, and
R S Duarte, and
E Pape
June 2003,
Journal of clinical pharmacology,
J M Parreira, and
L G Correia, and
E Pereira, and
R S Duarte, and
E Pape
January 1992,
Journal of cardiovascular pharmacology,
